Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | Epizyme, Inc. EPZM | Palo Alto Investors LP | 0 0.000% | -5,485,213 (Position Closed) | Filing History |
| 2022-09-08 4:01 pm Sale | 2022-08-31 | 13G | Epizyme, Inc. EPZM | PRIMECAP MANAGEMENT CO | 0 0.000% | -15,598,934 (Position Closed) | Filing History |
| 2022-08-12 7:32 pm Sale | 2022-08-12 | 13D | Archaea Energy Inc. LFG | Ipsen S.A. | 1,000 100.000% | -34,418,711 (-100.00%) | Filing History |
| 2022-08-09 4:01 pm Purchase | 2022-07-31 | 13G | Epizyme, Inc. EPZM | PRIMECAP MANAGEMENT CO | 15,598,934 9.270% | 251,157 (+1.64%) | Filing History |
| 2022-07-07 4:57 pm Purchase | 2022-06-27 | 13D | Archaea Energy Inc. LFG | Ipsen S.A. | 34,419,711 20.500% | 34,419,711 (New Position) | Filing History |
| 2022-06-28 08:32 am Purchase | 2022-06-27 | 13D | Epizyme, Inc. EPZM | RPI Finance Trust | 34,419,711 20.600% | 52,216 (+0.15%) | Filing History |
| 2022-02-14 5:11 pm Sale | 2021-12-31 | 13G | Epizyme, Inc. EPZM | Palo Alto Investors LP | 5,485,213 5.280% | -1,253,700 (-18.60%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Epizyme, Inc. EPZM | Redmile Group LLC | 3,832,475 3.500% | -6,392,930 (-62.52%) | Filing History |
| 2022-02-10 11:56 am Sale | 2022-01-31 | 13G | Epizyme, Inc. EPZM | PRIMECAP MANAGEMENT CO | 15,347,777 9.430% | -18,700 (-0.12%) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | Epizyme, Inc. EPZM | Vanguard Group Inc | 5,984,908 5.760% | -1,580,339 (-20.89%) | Filing History |
| 2022-02-09 5:22 pm Purchase | 2022-01-31 | 13G | Epizyme, Inc. EPZM | BlackRock Inc. BLK | 7,797,036 4.800% | 181,388 (+2.38%) | Filing History |
| 2022-02-08 2:03 pm Purchase | 2021-12-31 | 13G | Epizyme, Inc. EPZM | PRIMECAP MANAGEMENT CO | 15,366,477 14.790% | 157,950 (+1.04%) | Filing History |
| 2022-02-07 06:12 am Purchase | 2022-01-31 | 13D | Epizyme, Inc. EPZM | Hutchison China MediTech Ltd | 5,653,000 3.400% | 5,653,000 (New Position) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Epizyme, Inc. EPZM | BlackRock Inc. BLK | 7,615,648 7.300% | -295,380 (-3.73%) | Filing History |
| 2022-02-01 4:45 pm Purchase | 2022-01-31 | 13D | Epizyme, Inc. EPZM | RPI Finance Trust | 34,367,495 21.100% | 22,700,828 (+194.58%) | Filing History |
| 2021-08-16 07:20 am Purchase | 2021-08-07 | 13D | HUTCHMED (China) Limited HCM | Hutchison China MediTech Ltd | 5,653,000 5.200% | 5,653,000 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Epizyme, Inc. EPZM | Palo Alto Investors LP | 6,738,913 6.630% | 592,968 (+9.65%) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Epizyme, Inc. EPZM | Redmile Group LLC | 10,225,405 9.900% | 1,088,032 (+11.91%) | Filing History |
| 2021-02-12 12:02 pm Purchase | 2009-02-28 | 13G | Epizyme, Inc. EPZM | PRIMECAP MANAGEMENT CO | 15,208,527 14.970% | 140,100 (+0.93%) | Filing History |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | Epizyme, Inc. EPZM | Vanguard Group Inc | 7,565,247 7.450% | 758,914 (+11.15%) | Filing History |